在黎巴嫩女大学生中HPV疫苗接种率:一个横截面研究
Joey El Khoury1,2, Rami Halabi1,2, Mira Hleyhel3
1Notre Dame des Secours University Hospital Center, Street 93, Byblos Postal Code 3, Lebanon.
Journal of environmental and public health
|June 14, 2023
概括
在黎巴嫩女大学生中观察到人乳头瘤病毒 (HPV) 疫苗接种率较低. 增加的HPV知识和更高的父亲教育预测了更高的疫苗接种率,强调了有针对性的宣传活动的必要性.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 宫癌,通常是由人类乳头瘤病毒 (HPV) 引起的,是妇女的重大全球健康问题.
- 在黎巴嫩人群中,关于HPV知识和疫苗接种状况的研究非常稀缺.
- 这项研究通过检查黎巴嫩女大学生的HPV疫苗接种率来解决这一差距.
研究的目的:
- 为了确定在黎巴嫩的女大学生中HPV疫苗的流行率.
- 为了确定影响HPV疫苗接种率的预测因素.
- 评估有关HPV及其相关疫苗接种的知识水平.
主要方法:
- 在黎巴嫩进行了一项横截面的,匿名的在线调查,对454名17-30岁的女大学生进行了调查.
- 数据是在2021年2月24日至3月30日期间采集的,采用了封闭式问卷.
- 统计分析涉及双变量比较 (基平方,t测试) 和逻辑线性回归以确定疫苗接种预测因素.
主要成果:
- 在接受调查的女性大学生中,只有18.9%的女性接受过至少一剂HPV疫苗.
- 更高的疫苗接种率的主要预测因素包括更高的父亲教育水平和增加的HPV疫苗接种知识.
- 接种疫苗的障碍主要与对HPV和疫苗的知识不足有关;公立大学的学生的接种率较低.
结论:
- 该研究显示,黎巴嫩女大学生中HPV疫苗接种率低,对HPV及其疫苗的知识不足.
- 建议开展公共疫苗接种计划和有针对性的宣传活动,以提高HPV免疫率.
- 解决知识差距和社会经济因素对于加强宫癌预防策略至关重要.
更多相关视频
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
12.5K
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
27.5K
相关概念视频
01:51Vaccinations
44.8K
Overview
44.8K
01:08Prevalence and Incidence
644
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
644
01:30Cancer Vaccines
434
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
434